Skip to content
MyFreud

Anhedonia: When Nothing Feels Good Any More

Losing pleasure is a core part of depression and the part antidepressants treat least reliably. Naming it at an appointment changes what you get offered.

4 min read

Pop-art illustration of a person in profile beside a window, looking out towards a building opposite with a still expression.

Key takeaways

  • Anhedonia is the loss of pleasure or interest, and it is one of the two symptoms that can anchor a diagnosis of depression rather than a minor add-on to low mood.
  • It is not one thing. Research separates wanting a reward from liking it, and most people describe losing the wanting first, which is why things you still enjoy in the moment stop getting started.
  • It responds least reliably to the most commonly prescribed treatment. Reviews report that the benefit of some SSRIs on anhedonia specifically appears limited, even where mood and anxiety improve.
  • That makes it one of the commonest leftover symptoms after treatment, and leftover symptoms are associated with a higher risk of relapse. It is worth reporting rather than tolerating.
  • Naming it precisely at an appointment matters. "I feel nothing about things I used to like" points somewhere different from "I feel sad", and it can change which medication or therapy gets offered.

Anhedonia is the loss of pleasure and interest in things that used to matter, and it is not a minor accompaniment to depression. It is one of the two symptoms that can anchor the diagnosis on its own.

It is also the symptom people are worst at describing to a doctor, which matters, because describing it precisely can change what you are offered.

The distinction that explains the confusion

The most useful thing to know is that pleasure is not one system.

Reward research separates wanting, the motivation that moves you towards something, from liking, the pleasure once you have it. They are produced by partly different systems, and dopamine turns out to be necessary for the wanting and not for the liking. [berridge-1998-wanting-liking]

That split explains an experience people find impossible to articulate. You are not certain you would enjoy seeing a friend, so you do not arrange it. Nothing gets started, so nothing gets enjoyed, and the absence of evidence that you can still enjoy things becomes evidence that you cannot.

Most people lose the wanting before they lose the liking. Which means the thing you have concluded about yourself, that you no longer enjoy anything, is frequently untested rather than true.

What is actually missing Illustrative
0 25 50 75 100 How affected 85 Wanting to start 78 Anticipating enjoyment 34 Pleasure once doing it 45 Remembering it as good
0 25 50 75 100 How affected 80 Wanting to start 80 Anticipating enjoyment 88 Pleasure once doing it 82 Remembering it as good

A schematic of the wanting and liking distinction described in this article and in the reward research cited. Not measured data.

The third bar is where the two accounts diverge, and it is the one worth testing rather than assuming.

Why it matters clinically

Depression with prominent anhedonia is not simply more depression. It appears to behave differently.

A 2025 review looking at the clinical features of anhedonia in depression reported that the benefit of some selective serotonin reuptake inhibitors on anhedonia specifically seemed limited, while other approaches including psychotherapy and physical treatments showed potential. [wu-2025-anhedonia]

That is a consequential finding for anyone who has been treated and is still flat. The commonest first-line medication targets serotonin; the systems most implicated in reward and motivation involve dopamine and noradrenaline. A partial response where the sadness lifts and the flatness does not is a recognised pattern rather than a personal failure to respond.

Leftover symptoms are not neutral. Anhedonia is one of the most common residual symptoms after treatment for depression, and residual symptoms are associated with a higher risk of relapse. It is worth reporting rather than accepting as the new baseline.

There is a second possibility to hold alongside it. Some people describe a blunting of positive feeling as a side effect of antidepressants, which looks identical from the inside and needs a different response. Only a conversation with the prescriber can separate them, and that conversation does not happen if the symptom is never named.

Is this what is going on?

Tick anything true over the past fortnight. This is a reflection prompt rather than a test, and it produces no diagnosis.

0 of 7 ticked

The free depression screener uses the PHQ-9, whose first item asks directly about little interest or pleasure in doing things. It takes about two minutes and nothing is sent anywhere.

What helps

Say the specific sentence. “I feel nothing about things I used to enjoy” points somewhere different from “I feel sad”, and the two can lead to different prescriptions. If you have already been treated and the flatness stayed, say that too, because it is the detail that prompts a review.

Act before the motivation arrives. This is the direct implication of the wanting and liking split, and it is what behavioural activation is built on. If the missing component is the motivation to start, waiting until you feel like it means waiting for the broken part to repair itself. Scheduling in advance removes the decision from the moment you least want to make it.

Rate it afterwards, not before. Predicted enjoyment is unreliable in this state and actual enjoyment is often higher. Keeping a record is how the correction gets made, because memory in a low mood does not preserve the good hour.

Start smaller than feels worth doing. Fifteen minutes of something is a test of the hypothesis. An afternoon is a commitment you will cancel.

Ask about the medication rather than stopping it. Both a partial response and emotional blunting are worth raising, and both have options. Neither is a reason to stop taking something without advice. [nice-ng222-anhedonia]

Our guide to how to deal with depression covers the wider picture, and depression subtypes covers how presentations differ and why that changes treatment.

When to seek help

See a GP if the flatness has lasted two weeks or more and covers most of what you do, if you have stopped doing things you used to value, or if you are already being treated for depression and this part has not shifted.

In the UK you can self-refer to NHS talking therapies without going through a GP. Mention anhedonia by name or describe it plainly, because it is the detail most likely to be missed if you only report feeling low.

Go urgently if you have thoughts of harming yourself. In the UK, Samaritans is free on 116 123 at any hour, and you can text SHOUT to 85258.

How MyFreud can help

The belief that nothing is enjoyable any more is built out of memory, and memory in this state keeps the flat days and discards the tolerable ones. MyFreud gives you daily mood tracking that takes seconds, which is how you find out whether the hour you made yourself go was actually as empty as you predicted.

Download MyFreud and start today: App Store or Google Play.

Frequently asked questions

What is anhedonia?

It is a reduced ability to feel pleasure or interest in things that were previously enjoyable. It is one of the two core symptoms used to anchor a diagnosis of depression, alongside persistent low mood, and either can be enough. People describe food tasting of nothing much, music that no longer moves them, and friends they still care about in principle but feel nothing about seeing. It also occurs outside depression, including in schizophrenia and Parkinson disease.

Is anhedonia the same as depression?

No. It is a symptom that occurs in depression and in several other conditions, and someone can be depressed with low mood while still getting some pleasure from things. The distinction is useful clinically, because depression with prominent anhedonia is associated with a different profile and appears to respond differently to some treatments, which is why it is worth describing separately rather than folding into a general report of feeling low.

Why do antidepressants not fix anhedonia?

Some do help, but the class most often prescribed first appears to help it least reliably. Reviews report limited benefit from some selective serotonin reuptake inhibitors on anhedonia specifically, even where sadness and anxiety improve. One likely reason is mechanism: the reward and motivation systems most implicated in anhedonia involve dopamine and noradrenaline more than serotonin. Some people also describe a blunting of positive feeling as a side effect, which is a different problem with the same appearance and needs saying out loud.

What is the difference between not wanting to do something and not enjoying it?

That distinction is central and it is well supported. Reward research separates wanting, meaning the motivation that gets you moving towards something, from liking, meaning the pleasure once you have it. They run on partly different systems. Most people with anhedonia describe losing the wanting first, which produces a specific and confusing experience: things you would still enjoy if you were doing them never get started, so the evidence that you can still enjoy anything never arrives.

How do you treat anhedonia?

Start by naming it specifically to a doctor rather than reporting low mood in general, because it can change what is offered. Options include reviewing the medication, since agents acting on dopamine and noradrenaline are sometimes considered where reward and motivation are the main problem, and behavioural approaches that schedule activity in advance rather than waiting for the desire to return. The behavioural logic follows directly from the wanting and liking split: if motivation is what is missing, waiting to feel like it is waiting for the broken part to fix itself.

References

  1. 1.Wu C, Mu Q, Gao W, Lu S ( 2025). The characteristics of anhedonia in depression: a review from a clinically oriented perspective. Translational Psychiatry. doi:10.1038/s41398-025-03310-w
  2. 2.Berridge KC, Robinson TE ( 1998). What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?. Brain Research Reviews. doi:10.1016/S0165-0173(98)00019-8
  3. 3.National Institute for Health and Care Excellence ( 2022). Depression in adults: treatment and management (NG222). NICE. Link .
Somewhere to talk about this

Our Discord has a channel per topic and you pick the ones you want when you join, so you are not dropped into fourteen rooms at once. Reading without posting is completely fine. There are no clinicians in there, so it is other people rather than treatment.

Open the Discord